Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 27 | 2023 | 619 | 3.420 |
Why?
|
| Analgesics, Opioid | 17 | 2022 | 500 | 3.050 |
Why?
|
| Chronic Pain | 8 | 2021 | 149 | 2.420 |
Why?
|
| United States Department of Veterans Affairs | 16 | 2020 | 305 | 1.990 |
Why?
|
| Antipsychotic Agents | 11 | 2018 | 241 | 1.870 |
Why?
|
| Mental Health Services | 6 | 2020 | 233 | 1.560 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2019 | 389 | 1.340 |
Why?
|
| Rural Health Services | 5 | 2018 | 175 | 1.320 |
Why?
|
| Telemedicine | 7 | 2019 | 453 | 1.100 |
Why?
|
| Schizophrenia | 10 | 2009 | 267 | 1.080 |
Why?
|
| United States | 38 | 2023 | 5208 | 1.070 |
Why?
|
| Depressive Disorder | 3 | 2018 | 368 | 1.020 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 302 | 1.010 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 331 | 0.960 |
Why?
|
| Opioid-Related Disorders | 6 | 2022 | 367 | 0.930 |
Why?
|
| Primary Health Care | 5 | 2019 | 398 | 0.910 |
Why?
|
| Quality Indicators, Health Care | 4 | 2017 | 98 | 0.900 |
Why?
|
| Afghan Campaign 2001- | 3 | 2018 | 49 | 0.880 |
Why?
|
| Mental Disorders | 6 | 2020 | 445 | 0.870 |
Why?
|
| Substance-Related Disorders | 6 | 2021 | 671 | 0.850 |
Why?
|
| Depression | 4 | 2020 | 596 | 0.800 |
Why?
|
| Veterans Health | 3 | 2014 | 73 | 0.730 |
Why?
|
| Psychotherapy | 5 | 2019 | 106 | 0.710 |
Why?
|
| Middle Aged | 37 | 2021 | 13082 | 0.700 |
Why?
|
| Cooperative Behavior | 4 | 2015 | 253 | 0.680 |
Why?
|
| Adult | 34 | 2021 | 14207 | 0.670 |
Why?
|
| Community Health Centers | 2 | 2018 | 32 | 0.660 |
Why?
|
| Drug Utilization | 3 | 2017 | 73 | 0.660 |
Why?
|
| Ambulatory Care Facilities | 3 | 2018 | 138 | 0.660 |
Why?
|
| Hospitals, Veterans | 6 | 2014 | 125 | 0.660 |
Why?
|
| Male | 44 | 2021 | 27347 | 0.650 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 127 | 0.630 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 190 | 0.610 |
Why?
|
| Humans | 64 | 2023 | 54391 | 0.600 |
Why?
|
| Inappropriate Prescribing | 1 | 2017 | 20 | 0.600 |
Why?
|
| Off-Label Use | 1 | 2017 | 27 | 0.590 |
Why?
|
| Medicaid | 8 | 2021 | 268 | 0.580 |
Why?
|
| Aged | 28 | 2021 | 10060 | 0.580 |
Why?
|
| Female | 42 | 2021 | 28471 | 0.580 |
Why?
|
| Aftercare | 1 | 2017 | 82 | 0.580 |
Why?
|
| Drug Overdose | 4 | 2022 | 154 | 0.550 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 269 | 0.540 |
Why?
|
| Alcoholism | 4 | 2021 | 249 | 0.530 |
Why?
|
| Hospitalization | 3 | 2017 | 704 | 0.520 |
Why?
|
| Pain | 4 | 2021 | 405 | 0.510 |
Why?
|
| Urban Health Services | 1 | 2014 | 23 | 0.500 |
Why?
|
| Prescription Drugs | 1 | 2014 | 35 | 0.490 |
Why?
|
| Antidepressive Agents | 2 | 2014 | 187 | 0.480 |
Why?
|
| Patient Compliance | 3 | 2009 | 247 | 0.430 |
Why?
|
| Drug Prescriptions | 4 | 2018 | 89 | 0.430 |
Why?
|
| Health Services Accessibility | 5 | 2020 | 428 | 0.420 |
Why?
|
| Prevalence | 7 | 2020 | 1025 | 0.390 |
Why?
|
| Adolescent | 15 | 2020 | 6900 | 0.380 |
Why?
|
| Retrospective Studies | 16 | 2021 | 6459 | 0.360 |
Why?
|
| Young Adult | 12 | 2020 | 4318 | 0.360 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 3431 | 0.340 |
Why?
|
| Drug Utilization Review | 1 | 2008 | 26 | 0.330 |
Why?
|
| Biomedical Research | 3 | 2018 | 241 | 0.320 |
Why?
|
| Data Collection | 3 | 2008 | 320 | 0.320 |
Why?
|
| Mental Health | 2 | 2020 | 245 | 0.320 |
Why?
|
| Pain Measurement | 3 | 2021 | 248 | 0.300 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 311 | 0.300 |
Why?
|
| Patient Care Team | 4 | 2015 | 273 | 0.300 |
Why?
|
| Patient-Centered Care | 1 | 2008 | 132 | 0.280 |
Why?
|
| Pandemics | 2 | 2021 | 594 | 0.270 |
Why?
|
| Homes for the Aged | 1 | 2005 | 33 | 0.260 |
Why?
|
| Health Promotion | 1 | 2008 | 300 | 0.250 |
Why?
|
| Rural Population | 3 | 2019 | 598 | 0.250 |
Why?
|
| Psychotic Disorders | 1 | 2005 | 143 | 0.240 |
Why?
|
| Nursing Homes | 1 | 2005 | 126 | 0.240 |
Why?
|
| Treatment Refusal | 1 | 2004 | 41 | 0.240 |
Why?
|
| Schizophrenic Psychology | 1 | 2004 | 71 | 0.230 |
Why?
|
| Pirenzepine | 1 | 2003 | 4 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1696 | 0.230 |
Why?
|
| Drug Costs | 1 | 2003 | 35 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 543 | 0.220 |
Why?
|
| Risk Factors | 6 | 2020 | 3937 | 0.210 |
Why?
|
| Benzodiazepines | 2 | 2018 | 70 | 0.210 |
Why?
|
| Arkansas | 8 | 2021 | 2100 | 0.210 |
Why?
|
| Suicide | 1 | 2023 | 77 | 0.210 |
Why?
|
| Logistic Models | 7 | 2018 | 991 | 0.200 |
Why?
|
| Comorbidity | 3 | 2017 | 664 | 0.200 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 321 | 0.190 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 62 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 2390 | 0.180 |
Why?
|
| Buprenorphine | 1 | 2022 | 135 | 0.180 |
Why?
|
| Social Media | 1 | 2022 | 105 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 5 | 2008 | 489 | 0.180 |
Why?
|
| Age Distribution | 3 | 2018 | 199 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 53 | 0.170 |
Why?
|
| Depressive Disorder, Major | 2 | 2020 | 159 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 291 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 127 | 0.160 |
Why?
|
| Medication Adherence | 2 | 2009 | 133 | 0.160 |
Why?
|
| Urban Population | 1 | 2019 | 182 | 0.160 |
Why?
|
| Pharmacoepidemiology | 1 | 2017 | 7 | 0.150 |
Why?
|
| Mentors | 1 | 2018 | 55 | 0.150 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 30 | 0.150 |
Why?
|
| Standard of Care | 1 | 2017 | 16 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 184 | 0.150 |
Why?
|
| Universities | 1 | 2018 | 164 | 0.150 |
Why?
|
| Program Development | 1 | 2018 | 198 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2018 | 231 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2020 | 1546 | 0.140 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 6 | 0.140 |
Why?
|
| Dextropropoxyphene | 1 | 2015 | 5 | 0.140 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 430 | 0.130 |
Why?
|
| Chronic Disease | 4 | 2018 | 614 | 0.130 |
Why?
|
| Thrombosis | 1 | 2018 | 243 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2020 | 600 | 0.130 |
Why?
|
| Health Care Costs | 3 | 2015 | 175 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 182 | 0.130 |
Why?
|
| Curriculum | 1 | 2018 | 434 | 0.130 |
Why?
|
| Health Services | 2 | 2020 | 80 | 0.120 |
Why?
|
| Social Networking | 1 | 2014 | 15 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 742 | 0.120 |
Why?
|
| Insurance, Health | 2 | 2021 | 132 | 0.110 |
Why?
|
| Insurance Claim Review | 2 | 2009 | 28 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 136 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2008 | 1362 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 346 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 297 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2014 | 736 | 0.110 |
Why?
|
| Software | 1 | 2014 | 297 | 0.110 |
Why?
|
| Sex Factors | 1 | 2014 | 766 | 0.100 |
Why?
|
| Insurance Claim Reporting | 2 | 2009 | 9 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2019 | 4158 | 0.090 |
Why?
|
| Guideline Adherence | 2 | 2008 | 148 | 0.090 |
Why?
|
| Bipolar Disorder | 2 | 2008 | 209 | 0.090 |
Why?
|
| Anxiety | 2 | 2021 | 279 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2011 | 240 | 0.080 |
Why?
|
| Dementia | 1 | 2010 | 150 | 0.080 |
Why?
|
| Role Playing | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cognition | 1 | 2011 | 350 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 325 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 164 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 177 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2020 | 5612 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2023 | 683 | 0.070 |
Why?
|
| Child | 1 | 2019 | 7368 | 0.070 |
Why?
|
| Incidence | 3 | 2019 | 1083 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2005 | 61 | 0.070 |
Why?
|
| Social Justice | 1 | 2005 | 25 | 0.070 |
Why?
|
| Total Quality Management | 1 | 2004 | 27 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 36 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 3210 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 64 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 177 | 0.060 |
Why?
|
| Oregon | 1 | 2023 | 15 | 0.060 |
Why?
|
| Controlled Substances | 1 | 2022 | 4 | 0.060 |
Why?
|
| Risperidone | 1 | 2003 | 25 | 0.060 |
Why?
|
| Chlorpromazine | 1 | 2002 | 15 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 486 | 0.050 |
Why?
|
| Accidents | 1 | 2021 | 24 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 807 | 0.050 |
Why?
|
| Opiate Substitution Treatment | 1 | 2022 | 80 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 276 | 0.050 |
Why?
|
| Research Design | 1 | 2003 | 375 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 639 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 379 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 259 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 205 | 0.040 |
Why?
|
| Income | 1 | 2018 | 102 | 0.040 |
Why?
|
| Poverty | 1 | 2020 | 231 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 219 | 0.040 |
Why?
|
| Hawaii | 1 | 2018 | 126 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 206 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2018 | 95 | 0.040 |
Why?
|
| Mortality | 1 | 2017 | 102 | 0.040 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2016 | 46 | 0.040 |
Why?
|
| Health Status | 1 | 2018 | 368 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1199 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 125 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 308 | 0.030 |
Why?
|
| Videoconferencing | 1 | 2015 | 40 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 64 | 0.030 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 82 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2014 | 82 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 924 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 314 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 643 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 259 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 45 | 0.030 |
Why?
|
| Remission Induction | 1 | 2013 | 222 | 0.030 |
Why?
|
| Lipids | 1 | 2013 | 178 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2015 | 350 | 0.030 |
Why?
|
| Korean War | 1 | 2011 | 4 | 0.030 |
Why?
|
| World War II | 1 | 2011 | 11 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2013 | 587 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 489 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 712 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 59 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 309 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 65 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 363 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 354 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 161 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2008 | 195 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 35 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 53 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 30 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 80 | 0.020 |
Why?
|
| Veterans Disability Claims | 1 | 2006 | 3 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 159 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2007 | 63 | 0.020 |
Why?
|
| California | 1 | 2006 | 90 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1045 | 0.020 |
Why?
|
| Medicare | 1 | 2006 | 245 | 0.020 |
Why?
|
| Benchmarking | 1 | 2004 | 73 | 0.020 |
Why?
|
| Medication Systems, Hospital | 1 | 2002 | 5 | 0.010 |
Why?
|
| Hospitals, State | 1 | 2002 | 11 | 0.010 |
Why?
|
| Southeastern United States | 1 | 2002 | 55 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 2606 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 743 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 922 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2002 | 353 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 1322 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 14409 | 0.010 |
Why?
|